OR WAIT null SECS
August 06, 2025
Video
Nester describes the evolving C3G therapeutic landscape, the value of now having pegcetacoplan to offer patients, and trial data supporting its approval.
June 21, 2023
Gerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
Anuja Java, MD, discusses the role of complement inhibitors in transplant patients with C3G.
June 14, 2023
Carla M. Nester, MD, MSA, FASN discusses recent clinical trials on complement inhibitors for C3G.